Autologous cellular
therapy is the process whereby a patient's own cells are extracted, allowed to
multiply and then injected into the patient."

The new Tulip Disposable cannulas incorporate CellFriendly technology ,
which includes the implementation of certain lubricous coatings that the
company believes make surgical procedures less stressful on the patient and
easier for the plastic surgeon to use.

funnels microtubes

"This system could significantly reduce the time and
resources needed by any research or commercial lab that grows cells, while
ensuring the consistency of cell growth and reducing the potential for culture
contamination," said Dr. Mark P. Based on current market practices,
Protein Tomography is estimated to be a (U.

This news release contains forward-looking statements that include
statements about future development of, the market for and potential benefits
of TEM-based Protein Tomography to aid in drug development as well as the
expected size of that market.

tarsons urinalysis

An aesthetic dermal application is currently available in the UK and is
in Phase III pivotal clinical trials in the US. In addition to
dermal indications, Isolagen is researching the use of autologous cellular
therapies to treat gum recession, acne scarring and wound healing among other
indications.
"We are confident that we can maintain the quality and consistency of cell
production, realize substantial savings and gain tremendous efficiencies
through the use of the ACE System," said Mr. The company's products for NanoBiology address a robust set
of applications including 3-D cryo TEM and SEM applications and nanoparticle
characterization and analysis.
Cell Bio-Systems, Inc."

About Cell Bio -Systems, Inc.

beakers distributioner

fei.

This press release contains certain forward-looking information about Cell
Bio-Systems, Inc.

tarsons mettler

The ACE system could
be used by cell and tissue companies worldwide and a successfully implemented
ACE system would dramatically improve the time and cost of propagating and
harvesting cells."
Experts in the cell biology field acknowledge the potential significance
of the ACE technology. Based on the
accumulated experience of the company through its pre-clinical studies ,
clinical trials and treatment of patients in the United Kingdom, the company
believes that the Isolagen Process utilizing a patient's own cells creates a
safe and effective therapy for facial rejuvenation. As we move from the genomics to the proteomics era, we will continue
to identify customer needs and work to deliver the advanced applications that
our growing and diverse life science market , which we refer to as NanoBiology,
demands.

PRESS RELEASE Cell Bio-Systems Inc.(R) Unveils New Line of Tulip(R) Disposable Plastic Surgery Instruments at Plastic Surgery 2005 Show

microplate microtubes

The Isolagen Process
begins when a physician takes a small tissue sample from which millions of
fibroblast cells are extracted and allowed to multiply in the laboratory.

ACE Advances Cell Propagation
The ACE unit consists of two separate and distinct parts.
The design eliminates nearly all human intervention, dramatically reducing
the chance of contamination and the technical labor and monitoring associated
with the process. The ACE design
secures and records the identification of each patient 's cells through every
step of the process -- from biopsy to injection -- creating a clear electronic
chain of custody., FEI Company
(Nasdaq: FEIC) and Sweden-based Sidec Technologies AB today announced that the
two companies will collaborate on the commercialization of Protein Tomography
solutions and services based on Sidec's proprietary software and intellectual
property, and FEI's transmission electron microscopes (TEMs). Plastic Surgery 2005 is
scheduled to occur between September 24th and September 27th, 2005. Founded in 2004, Cell Bio-Systems is a
Medical Device, Biotechnology Company seeking to manufacture and distribute
patented technologies for the Plastic & Cosmetic Surgery, Biopsy ,
Orthopedic Surgery, Stem Cell Therapy and other Living Tissue markets., that
could cause actual results to differ materially from those expressed in, or
implied or projected by, the forward-looking information and statements. Readers are cautioned not
to place undue reliance on these forward-looking statements.

sterile pipettes

"We've invested significant resources to make the cell propagation process
scalable , consistent and cost-efficient," said Isolagen's Chairman and interim
CEO Frank DeLape.
"The original business plan for Isolagen called for a single lab in every
country, so the concept of scalability was not a priority," said Mr. Pre-clinical and clinical
studies for future autologous therapies are ongoing.com . Four new products, part of a growing line of new
instruments, will be unveiled to over 2,000 surgeons at Plastic Surgery
2005 (ASPS), the nation's largest show focusing on education and products
related to the plastic surgery industry.

serology centrifuge

Sidec is pioneering the field of protein imaging
using cryo electron tomography and has several research collaborations with
global pharmaceutical companies.
Protein Tomography consists of advanced electron microscopy
instrumentation, proprietary data acquisition and reconstruction software as
well as scientific expertise to enable the imaging and analysis of individual
protein molecules in cells and tissues. "It was important
to us to incorporate the Tulip brand name on these products because
plastic surgeons know and trust the brand .

coagulation serology

The first is a
permanent unit, housing circuitry, pumps and a thermo-electric heater. "Although ACE was
developed to provide large-scale improvements in capacity and operating
margins for the production of the Isolagen Process, we believe that ACE
represents substantial improvements in cell propagation and harvesting for
many other applications. Cells will be contained in a cell tower , which is designed
to accommodate the expansion and growth of the cells and monitor cell growth
and cell count to effectively predict when the target number of cells will be
reached.

About Isolagen
Isolagen specializes in the development and commercialization of
autologous cellular therapies for soft and hard tissue regeneration. "Many drugs fail when they progress from pre-clinical studies to
clinical trials.

"Instruments and products in plastic surgery continue to evolve .

distributioner tarsons

More information can be found at http://www. With R+D centers in North America and Europe,
and sales and service operations in more than 50 countries around the world,
FEI is bringing the nanoscale within the grasp of leading researchers and
manufacturers and helping to turn some of the biggest ideas of this century
into reality. More information can be found on the FEI website at:
http: //www. Just like
plastic replaced glass in the disposable syringe market years ago, our new
products give plastic surgeons modern instrumentation options," according
to Cell Bio-Systems President and COO, Darin Andersen. "Our close
relationship with Tulip Medical, the most trusted and well known name in
the reusable cannula market, is critical to the launch of this new line. Such statements are
subject to certain risks and uncertainties, many of which are difficult to
predict and generally beyond the control of Cell Bio-Systems, Inc.

microplates vitrex

"
FEI has led the development of cryo electron microscopy for the imaging of
biological structures in close collaboration with many top level academic
groups in Europe and the US.

Cell Bio-Systems, Inc. ("Cell Bio-Systems") which is intended to be covered by
the safe harbor for "forward-looking statements" provided by the Private
Securities Litigation Reform Act of 1995.
These risks and uncertainties include: our lack of operating revenue and
earnings history, our need for additional capital to pursue our business
strategy, the grade and quantity of minerals in our projects may not be
economic, we do not have fee title to our properties, but derive our right
through leases and the Mining Law, we are a non-reporting company and as
such do not make periodic filings with the Securities and Exchange
Commission, we trade on the Pink Sheets and there can be no assurances that
a liquid market will develop in our securities.

tarsons serology

In addition , Isolagen intends to utilize cryogenic preservation and
freezing technology to allow maximum flexibility in scheduling treatments.

For additional information, please visit: http://www. Protein Tomography(TM) to Improve Success in Drug Development

HILLSBORO, Ore. Imaging and comparing drug targets from different species
using Protein Tomography provides insight into the molecular differences
underlying this attrition."

About Sidec Technologies AB
Sidec Technologies AB provides solutions to significantly improve the
predictive value of pre-clinical experiments.

"

Tulip is a well established brand in re-usable cannulas currently used
worldwide in many procedures such as Liposuction, Body Sculpting, Fat
Transfer and more.

mettler serology

Proprietary ACE System Improves Commercial Manufacturing for Isolagen and
Creates Potential Global Market Licensing Opportunity

EXTON, Pa., Isolagen (Amex: ILE), which
specializes in the development and commercialization of autologous cellular
therapies for tissue regeneration, today unveiled a design for an automated
system to propagate and harvest cells more efficiently and cost-effectively
than other cell harvesting systems currently available." Mr. The
second part is the disposable unit, which contains a "cell tower," media bags,
cell separator and a sterile tubing for media flow.
Every step, from feeding the cells to the harvesting of the injection
syringes, will be executed in a sterile, closed-loop system."
The Isolagen ACE system was designed in collaboration with Fairway Medical
Technologies and International Biophysics Corporation, leaders in medical
device and equipment technology.

Next Steps
Isolagen intends to introduce ACE technology in the UK and its new Swiss
facility during 2006.
"Understanding drug targets and the disease mechanisms on a molecular
level is extremely difficult, resulting in severe problems when translating
bench research into human biology ," commented Hans Johansson, president and
CEO of Sidec.
"We have a long-standing reputation for providing enabling tools for life
science.com.

"Plastic surgeons and their customers have been anticipating a disposable
instrument solution in this market for years," says Andersen.

serology spi

Isolagen Unveils Automated Cellular Expansion (ACE) System

DeLape. With offices in Stockholm and Lund, Sweden and San Diego,
California, Sidec offers contract research to the pharmaceutical industry and
academic institutions. Please also refer to our Form 10-K, Forms 10-Q,
Forms 8-K and other filings with the U.

syringes tarsons

A Biologics License
Application is expected to be filed with the FDA in late 2005. Factors that could affect these forward-looking
statements include but are not limited to the inability of FEI or Sidec to
successfully complete the development described, the emergence of competing
technologies that offer more effective or less expensive solutions to TEM-
based Protein Tomography, failure of the new application to function as
expected, failure of the market to develop as expected and the inability of
customers to develop and deploy the expected new applications or to achieve
the performance described. "Today's
plastic surgeons have greater demands on their time as well as increased
regulatory oversight of their industry. These
statements include, but are not limited to, financial projections and
estimates and their underlying assumptions; statements regarding plans,
objectives and expectations with respect to future operations, products and
services; and statements regarding future performance .

Such as syringes, plastic lab ware, disposable lab coats etc.

urinalysis microplate

DeLape.
Protein Tomography is a new technology developed to address critical
issues around drug target validation and translational medicine in the
pharmaceutical industry, improving target validation processes and shortening
development time for new pharmaceuticals.

"Tulip Disposable Products, and specifically our new Tulip Disposable
cannulas, represent a new era in instrumentation and related products for
our biggest customer , plastic surgeons," said Marc Pilkington, CEO of Cell
Bio-Systems, maker of the Tulip Disposable line of products. Words such as "expect(s),"
"feel(s)," "believe(s)," "will," "may," "anticipate (s)," and similar
expressions are intended to identify forward-looking statements.

10/22/00

centrifuge serology

And, the footprint of the Isolagen ACE unit as designed is
small, allowing for modular stacking and maximum space efficiency. Following the anticipated successful implementation
of ACE for the Isolagen Process, we intend to seek licensing opportunities
with other cell-based companies thereby creating a new revenue stream for our
shareholders.

Logistical Advances Inherent with ACE
This fully automated, sterile closed-loop system is designed to offer
enhanced benefits for other aspects of the Isolagen Process.

Forward-looking statements in this press release are made pursuant to the
safe harbor provisions of the federal securities laws. Isolagen, Inc. Cell
Bio -Systems will manufacture, market, and distribute medical devices,
adapted with these and other patented technologies, to physicians, clinics,
military, health organizations, hospitals and other distribution outlets.

These sites are from companies that make, manufacture, distribute or sale primarily general -purpose lab consumables and disposable supplies.

vials tarsons

Cells are placed within
the cell tower, which is designed to accommodate the growth of the cells,
eliminating the time-consuming transfer of growing cells into new flasks.

About FEI
FEI's Tools for Nanotech(TM), featuring focused ion - and electron-beam
technologies, deliver 3D characterization, analysis and modification
capabilities with resolution down to the sub-Angstrom level and provide
innovative solutions for customers working in NanoBiology, NanoResearch and
NanoElectronics. Our Tulip Disposable cannulas
address the current environment by providing plastic surgeons with
disposable cannulas that are cost effective when compared to traditional
reusable products, yield better and more efficient outcomes, and are safer
for patients.

disposables spi

Isolagen is best known for its patented Isolagen Process in which a
patient 's own cells are used to correct and reduce the normal effects of aging
and replenish deficiencies caused by the loss of fibroblast cells as a person
ages.

Growing Cells: Effective But Not Efficient
Cell propagation in Isolagen's London and Houston laboratories is
effective , but labor-intensive and time consuming.
"Our science has advanced to the point that we now envision a single
laboratory serving multiple continents utilizing an efficient method of cell
propagation and harvesting on a commercial scale. Information contained
in forward-looking statements is based on current expectations and is subject
to change, and actual results may differ materially from the forward-looking
statements.com. Tulip has a history dating back to the early 1990s
when the name was used to describe the original cannulas used to connect to
syringes for use in Liposuction and the introduction of the Syringe System
now commonly used in related procedures. (OTC: CBSI) is a Nevada corporation whose operations
are based in San Diego, California. Forward-looking statements are
statements that are not historical facts.

funnels coagulation

The announcement was made at the UBS 2005 Global
Pharmaceuticals Conference in New York., does not undertake to update any such forward-
looking statements or to publicly announce developments or events relating to
the matters described herein.

disposables perfector

Lewis, Director of Research Operations and
Senior Lecturer at Eastman Dental Institute of University College London . The
regenerated fibroblast cells are then injected into the patient's wrinkles
when the cells reach a target quantity. FEI and Sidec offer this as a service
through Sidec, as an on-premises service , or through a software and other
intellectual property license arrangement combined with a TEM system sale. (OTC: CBSI)
announced today the release of its new line of disposable cannulas for the
plastic surgery market.
Cell Bio-Systems does not undertake any obligation to republish revised
forward -looking statements to reflect events or circumstances after the
date hereof or to reflect the occurrence of unanticipated events.

spi coagulation

In preparing for its global market launch, Isolagen devoted significant
resources to create a system that would make cell propagation and harvesting
scalable and more efficient. Several years ago, a team of Isolagen scientists
and engineers set out to design an automated cellular expansion (ACE) system
that would substantially improve capacity and operating margins.

isolagen.

The company's proprietary 3-D
reconstruction technology and electron tomography enables the visualization of
disease events at a molecular level, in virtually any environment and
biological context, thereby bridging the current gap between the test tube and
human biology.

sidec. Securities and Exchange Commission
for additional information on these factors and other factors that could cause
actual results to differ materially from the forward-looking statements. FEI
assumes no duty to update forward-looking statements

disposables plasticware

FEI and Sidec Tackle Validation of Drug Targets

) $200 million market with the
potential to grow several fold within a few years.
"FEI is very pleased to offer this advanced solution for Protein
Tomography with Sidec," commented Vahe Sarkissian, president and CEO of FEI.

distributioner lancets

"The Automated Cellular Expansion (ACE) System is a simple
solution that should enable us to introduce the Isolagen Process on a global
scale, and will allow us to pursue licensing opportunities with organizations
engaged in cell propagation and harvesting. DeLape noted the
company recently announced the acquisition of a facility in Neuchatel,
Switzerland intended to service Europe, Asia and Africa, and the purchase of a
lab in Exton, PA to service the Central and South America and the United
States once FDA approval is obtained. The
company's product candidates are based on its proprietary Isolagen Process and
are directed toward dermatology -- facial rejuvenation, gingival disease --
gum disease, vocal cord lesions, and wound treatment.S.S.

coagulation mettler

Isogalen 's product candidates
are designed to be minimally invasive and nonsurgical.
Cell Bio-System is the exclusive licensee of patented syringe connection
devices which use the worldwide recognized Tulip brand name.